不同血管通路对血液透析患者的有效性及安全性  

The effectiveness and safety of different vascular access for hemodialysis patients

作　　者：唐福仙 庞欣杰 梁苇茜 TANG Fu-xian;PANG Xin-jie;LIANG Wei-qian(Department of Nephrology,Huaiji County People's Hospital,Zhaoqing 526400,China)

机构地区：[1]怀集县人民医院肾内科,526400

出　　处：《中国实用医药》2022年第17期67-69,共3页China Practical Medicine

摘　　要：目的 探讨不同血管通路对血液透析患者的有效性及安全性。方法 90例血液透析患者作为研究对象,根据随机数字表法分为甲组、乙组及丙组,各30例。甲组患者的血管通路为自体静脉内瘘,乙组患者的血管通路为聚四氟乙烯移植血管瘘,丙组患者的血管通路为袖套隧道导管。比较三组患者血液透析充分性及并发症发生率。结果 甲组尿素清除指数(Kt/V)为(1.58±0.25),乙组Kt/V为(1.56±0.31),丙组Kt/V为(1.61±0.28);三组患者Kt/V比较差异无统计学意义(P>0.05)。甲组并发症发生率为6.67%,乙组并发症发生率为10.00%,丙组并发症发生率为3.33%;三组患者并发症发生率比较差异无统计学意义(P>0.05)。结论 不同血管通路均能保证血液透析患者的透析充分性,且在并发症风险方面均较低,可根据患者实际情况合理选择血管通路,保证透析效果。Objective To discuss the effectiveness and safety of different vascular access for hemodialysis patients.Methods A total of 90 hemodialysis patients were selected as the research subjects and divided into group A,group B and group C according to the random numerical table,with 30 cases in each group.The vascular access in group A was autologous intravenous fistula,the vascular access in group B was polytetrafluoroethylene graft fistula,and the vascular access in group C was cuff tunnel catheter.The adequacy of hemodialysis and complication rate were compared among the three groups.Results The urea clearance index(Kt/V)of group A was(1.58±0.25),the Kt/V of group B was(1.56±0.31),and the Kt/V of group C was(1.61±0.28);there was no statistically significant difference in Kt/V among the three groups(P>0.05).The complication rate of group A was 6.67%,that of group B was 10.00%,and that of group C was 3.33%;there was no statistically significant difference in the complication rate among the three groups(P>0.05).Conclusion Different vascular access can ensure the adequacy of dialysis for hemodialysis patients,and the risk of complications is low.The vascular access can be selected reasonably according to the actual situation of the patient to ensure the dialysis effect.

关 键 词：血液透析 自体静脉内瘘 聚四氟乙烯移植血管瘘 袖套隧道导管 血管通路 

分 类 号：R692.5[医药卫生—泌尿科学]